Tempus AI is trading at $75.17, down -10.03%, with no clear company-specific catalyst for the October 6 decline confirmed in available reporting.

  • Broader markets were higher, and no specific sector catalyst was identified.
  • FDA clearance for ECG-MR was reported earlier and coincided with the prior session’s gain.
  • Available market reports show conflicting prices and directions; the supplied price context is used for the movement above.